Amino acid sequences facilitating penetration of a substance...

Details Amino acid sequences facilitating penetration of a substance... Amino acid sequences facilitating penetration of a substance...

2011-08-23

2011-08-23

Ewoldt, Gerald R (Department: 1644)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S326000, C530S391700, C530S402000

Reexamination Certificate

active

08003595

ABSTRACT:
The invention concerns an amino acid sequence capable of facilitating penetration of a substance of interest into cells and/or cell nuclei, characterized in that it is capable of reacting in vivo with aminoglycans. Optionally the sequence is derived from a protein of human origin.

REFERENCES:
patent: 3710795 (1973-01-01), Higuchi et al.
patent: 4526888 (1985-07-01), Williams et al.
patent: 5262564 (1993-11-01), Kun et al.
patent: 5521291 (1996-05-01), Curiel et al.
patent: 5547929 (1996-08-01), Anderson et al.
patent: 5624894 (1997-04-01), Bodor
patent: 5635383 (1997-06-01), Wu et al.
patent: 6043339 (2000-03-01), Lin et al.
patent: 6066485 (2000-05-01), Guthridge et al.
patent: 6274712 (2001-08-01), Springer et al.
patent: 6635248 (2003-10-01), Ternynck et al.
patent: 6750321 (2004-06-01), Chen et al.
patent: 6855801 (2005-02-01), San Antonio
patent: 7049286 (2006-05-01), Tchelingerian
patent: 7112562 (2006-09-01), Tchelingerian
patent: 2003/0153490 (2003-08-01), Tchelingerian
patent: 2003/0199677 (2003-10-01), Avrameas et al.
patent: 2004/0123343 (2004-06-01), La Rosa et al.
patent: 2007/0042492 (2007-02-01), Avrameas
patent: 2007/0259813 (2007-11-01), Arranz
patent: 2 766 826 (1999-02-01), None
patent: WO 90/12587 (1990-11-01), None
patent: WO 91/04315 (1991-04-01), None
patent: WO 94/28921 (1994-12-01), None
patent: WO 96/08274 (1996-03-01), None
patent: WO 96/38163 (1996-12-01), None
patent: WO 97/02840 (1997-01-01), None
patent: WO 98/40401 (1998-09-01), None
patent: WO 98/56938 (1998-12-01), None
patent: WO 99/06632 (1999-02-01), None
patent: WO 99/07414 (1999-02-01), None
patent: WO 99/32136 (1999-07-01), None
patent: WO 99/67284 (1999-12-01), None
patent: WO 00/45831 (2000-08-01), None
patent: WO 0164738 (2001-09-01), None
patent: WO 03/018636 (2003-03-01), None
patent: WO 03/092736 (2003-11-01), None
patent: WO 03/106491 (2003-12-01), None
patent: WO 2004/011033 (2004-02-01), None
patent: WO 2005/016960 (2005-02-01), None
Ngo et al. The Protein Folding Problem and Tertiary Structure Prediction, Merz and LeGrand, Birkhauser Boston, pp. 491-495, 1995.
Grieb et al. Biochem. Biophys. Res. Comm. 1998, vol. 246, pp. 182-191.
Fromm et al. Arch. Biochem. Biophsy. 1997, vol. 343, No. 1, pp. 92-100.
A—Genseq Accession No. AAW99570. Jun. 22, 1999, 2 pages.
Ma et al. Biotech. Bioeng. 1992, 40: 530-536.
Brian R. Stoll et al., “A mechanistic analysis of carrier-mediated oral delivery of protein therapeutics,” Journal of Controlled Release, 64 (2000) 217, 218, Elsevier, XP-002241926.
International Search Report dated Sep. 17, 2003 for PCT/IB02/03916.
Written Opinion dated Sep. 22, 2003 for PCT/IB02/03916, first two pages only.
Amara, et al, J. Biol. Chem., vol. 274, p. 23916-23925, 1999.
Arkonac, et al., J. Biol. Chem., vol. 273, p. 4400-4405, 1998.
Avrameas, et al., Proc. Natl. Acad. Sci., vol. 95, p. 5601-5606, 1998.
Campanelli, et al., Development, vol. 122, p. 1663-1672, 1996.
Cardin, et al., Biochem. Biophys. Res. Com., vol. 154, p. 741-745, 1988.
Cardin & Weintraub, Arteriosclerosis, vol. 9, p. 21-32, 1989.
David, FASEB J., vol. 7, p. 1023-1030, 1993.
Fowlkes, et al., Endocrinol., vol: 138, p. 2280-2285, 1997.
GenBank Accession No. 600165A, 1992.
GenBank Accession No. 550085A, 1992.
GenBank Accession No. AAH05255, Jul. 2001.
GenBank Accession No. AAA59179, 1995.
Xu, et al., Glyconjug J., vol. 13, p. 81-90, 1996.
Hasan, et al., J. Immunol., vol. 162, p. 1064-1070, 1999.
Hirabayashi, et al., Scand. J. Immunol., vol. 37, p. 533-540, 1993.
Inoue, et al., FEBS, vol. 269, p. 89-92, 1990.
Javadpour, et al., J. Med. Chem., vol. 39, p. 3107-3113, 1996.
Kalsi, et al., Lupus, vol. 4, p. 375-389, 1995.
Lortat-Jacob & Grimaud, FEBS, vol. 280, p. 152-154, 1991.
Maher, et al., Mol. Cell. Biol., vol. 9, p. 2251-2253, 1989.
Bernfield, et al., Annu. Rev. Cell. Biol., vol. 8, p. 365-393, 1992.
Pohl, et al., FEBS, vol. 272, p. 200-204, 1990.
Stevenson, et al., J. Autoimmunity, vol. 6, p. 809-825, 1993.
Yayon, et al., Cell, vol. 64, p. 841-848, 1991.
Partial International Search Report for PCT/IB02/03916, mailed Jun. 23, 2003.
PCT Written Opinion for PCT/IB02/03916, 2003.
Avrameas, et al. (1999) Bioconjugate Chemistry 10(1) : 87-93.
Bosanquet (1986) Cancer Chemother. Pharmacol. 18: 176-179.
Caldwell, et al. (1996) Int. J. Biochem. Cell Biol. 28: 203-216.
Castellot, et al. (May 1986) J. Cell Biol. 102: 1979-1984.
Darveau, et al. (1991) Antimicrobial Agents and Chemotherapy 35(6): 1153-1159.
Dini, et al. (1996) Cellular and Molécular Biology 42(2): 269-277.
Esko, et al. (1985) Proc. Natl. Acad. Sci. 82: 3197-3201.
Guevara, et al. (1999) Journal of Protein Chemistry 18(8): 845-857.
Gueritte-Voegelein (1991) J. Med. Chem. 34: 992-998.
Hirsch (1991) New Engl. J. Med. 324: 1565-1574.
Kallunski & Tryggvason (Jan. 1992) The Journal of Cell Biology 116(2): 559-571.
Lookene, et al. (2000) Biochemistry 39: 230-236.
Margalit, et al. (1993) Journal of Biological Chemistry 265(26): 19228-19231.
Mesri, et al. (1994) Journal of Cell Science 107 : 2599-2608.
Morrow J. Biol. Chem. 273(32): 20114-20120, 1998.
Niidome, et al. (1999) Bioconjugate Chemistry 10(5): 773-780.
Nogales (1999) Cell. Mol. Life Sci. 56: 133-142.
Ohta, et al. (Apr. 1994) Free Radical Biology & Medicine 16(4): 501-507.
Olofsson, et al. (1999) Journal of Clinical Investigation 4: 885-894.
Park, et al. (Mar. 6, 1998) Biochem. Biophys. Res. Commun. 244(1): 253-257.
Pasqualini, et al. (1997) Nature Biotech. 15: 542-546.
Robinson (1963) Adv. Lip. Res. 1:1 133-182.
Rostand and Esko (Jan. 1997) Infection and Immunity 65(1): 1-8.
Ruoslahti & Yamazuchi (Mar. 1991) Cell 64: 867-869.
Silber, et al. (Nov. 15, 1994) Blood 84(10): 3440-3446.
Tabosa Do Egito, et al. (Sep. 1996) J. Antimicrob. Chemother. 38(3): 485-497.
Ternynck, et al. (1987) “Techniques immunoenzymatiques” Editions INSERM pp. 29-121.
Travis J. (Oct. 5, 1994) Journal of the National Cancer Institute 86(19): 1450-1457.
Wall and Wani (Feb. 15, 1995) Cancer Research 55: 753-760.
Weisgraber and Rall (1987) Journal of Biological Chemistry 262(23): 11097-11103.
Zunino, et al. (1999) Drug Resistance Updates 2: 351-357.
International Preliminary Examination Report for International Patent Application No. PCT/FR01/00613 mailed Sep. 2, 2006.
International Search Report for International Patent Application No. PCT/IB2004/002936 mailed Feb. 10, 2005.
International Search Report for International Patent Application No. PCT/FR2004/002142 mailed Apr. 26, 2005.
Written Opinion for International Patent Application No. PCT/FR2004/002142 mailed Apr. 26, 2005.
French Search Report for FR 0002621.

Affiliated with

Also associated with

Rating

Amino acid sequences facilitating penetration of a substance... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amino acid sequences facilitating penetration of a substance..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino acid sequences facilitating penetration of a substance... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2778058